Small Pharma (AgeTech UK) NeuroTech

Psychedelics for depression.Forging a new path in pharmaceutical development by bridging the gap between academia and industry. With specific experience in IP and the drug development process, they integrate a robust IP strategy with the development plan required to guide close-to-clinic candidates through the clinical trials necessary to demonstrate proof-of-concept in patients.
Technology: AgeTech Companies
Industry: UK AgeTech 2020
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership